Background: Since the 1970s there have been few epidemiological studies of scrotal cancer. We report on the descriptive epidemiology of scrotal cancer in the Netherlands. Methods: Data on all scrotal cancer patients were obtained from the Netherlands Cancer Registry (NCR) in the period 1989-2006 and age-standardised incidence rates were calculated also according to histology and stage. Relative survival was calculated and multiple primary tumours were studied. Results: The overall incidence rate varied around 1.5 per 1 000 000 person-years, most frequently being squamous cell carcinoma (27%), basal cell carcinoma (19%) and Bowen's disease (15%). Overall 5-year relative survival was 82%, being 77% and 95% for patients with squamous and basal cell carcinoma, respectively. In all, 18% of the patients were diagnosed with a second primary tumour. Conclusion: The incidence rate of scrotal cancer did not decrease, although this was expected; affected patients might benefit from regular checkups for possible new cancers.

, , , , , , , , , , , , , , , , , , , , , , ,,
British Journal of Cancer
Erasmus MC: University Medical Center Rotterdam

Verhoeven, R.H.A, Louwman, W.J, Koldewijn, E.L, Demeyere, T.B.J, & Coebergh, J.W.W. (2010). Scrotal cancer: Incidence, survival and second primary tumours in the Netherlands since 1989. British Journal of Cancer, 103(9), 1462–1466. doi:10.1038/sj.bjc.6605914